Live Breaking News & Updates on நிதி கருவிகள் சந்தை
Stay updated with breaking news from நிதி கருவிகள் சந்தை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Opinion of the Management Board of JSC Olainfarm on the offer of mandatory share buy-back of the company and its impact on the public interest finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GPW Group's Record-High Revenue And EBITDA In 2020 mondovisione.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondovisione.com Daily Mail and Mail on Sunday newspapers.
Information expressed in the public domain by the Repharm Group is deceptive and contradictory Today, on February 19, information has arrived in the public domain that the company from Repharm Group will acquire the shares of JSC “Olainfarm” directly and indirectly owned by Anna Emilija Maligina. The Chairman of the Management Board of JSC Olainfarm Jeroen Weites points out that Signe Baldere - Sildedze, the legal representative of Anna Emilija Maligina, has informed the Board of JSC Olainfarm that the information in the public domain is false and the deal entered with SIA Farma Fund (previous name Zdorovie Europe) is not valid. Consequently, there is no basis for Repharm group to make such a statement. ....
Olainfarm: Information expressed in the public domain by the Repharm Group is deceptive and contradictory Today, on February 19, information has arrived in the public domain that the company from Repharm Group will acquire the shares of JSC Olainfarm directly and indirectly owned by Anna Emilija Maligina. The Chairman of the Management Board of JSC Olainfarm Jeroen Weites points out that Signe Baldere - Sildedze, the legal representative of Anna Emilija Maligina, has informed the Board of JSC Olainfarm that the information in the public domain is false and the deal entered with SIA Farma Fund (previous name Zdorovie Europe) is not valid. Consequently, there is no basis for Repharm group to make such a statement. ....